Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Reexamination Certificate
2008-07-03
2011-10-11
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
Reexamination Certificate
active
08034797
ABSTRACT:
The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
REFERENCES:
patent: 1282757 (1972-07-01), None
International Search Report mailed Sep. 16, 2008 for International Application No. PCT/EP2008/058600, two pages.
Forster Heinz
Kalbe Jochen
Reiter Rudolf
Fetterolf Brandon
Rankin , Hill & Clark LLP
Ricci Craig
Trin Therapeutics GmbH
LandOfFree
Triazene compounds for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazene compounds for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazene compounds for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4254606